---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-056901"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:57:52.714382+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Incannex appoints Dr. Kirsch to OSA board; Phase 2 data due July 2025

## Summary
- Appointed Douglas B. Kirsch, M.D., FAAN, FAASM to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
- Dr. Kirsch is Medical Director of Atrium Health Sleep Medicine and former President of the American Academy of Sleep Medicine.
- Company expects to report topline Phase 2 data from the U.S. RePOSA study in July 2025.
- Phase 3 initiation for IHL-42X targeted for later in 2025.

## SEC filing metadata
- accession: 0001213900-25-056901
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/0001213900-25-056901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/ea0246656-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-056901
- JSON: https://secwatch.observer/filing/0001213900-25-056901.json
- Plain text: https://secwatch.observer/filing/0001213900-25-056901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.